Imaging features of sporadic breast cancer in women under 40 years old: 97 cases. 2013

Bénédicte Bullier, and Gaétan MacGrogan, and Hervé Bonnefoi, and Gabrielle Hurtevent-Labrot, and Edouard Lhomme, and Véronique Brouste, and Martine Boisserie-Lacroix
Department of Radiology, Institut Bergonié, Comprehensive Cancer Centre, F-33000, Bordeaux, France.

OBJECTIVE To evaluate characteristic features of mammography, ultrasound and magnetic resonance imaging (MRI) of sporadic breast cancer in women <40 years and to determine correlations with pathological and biological factors. METHODS A retrospective review of radiological, clinicopathological and biological features of sporadic breast cancers for women under 40 years at our institution between 2007-2012 covering 91 patients. Mammography was available for 97 lesions, ultrasound for 94 and MRI for 38. RESULTS The most common imaging features were masses, nearly all classified BI-RADS 4 or 5. On mammography microcalcifications alone accounted for 31 %, all suspicious. There were 42.6 % luminal B, 24.5 % luminal A, 19.1 % HER2-enriched and 10.6 % triple-negative (TN) tumours by immunohistochemistry. HER2 overexpression was correlated with the presence of calcifications at mammography (P = 0.03). TN cancers more often had an oval shape and abrupt interface at ultrasound and rim enhancement on MRI. MRI features were suspicious for all cancers and rim enhancement of a mass was a significant predictor of triple-negative tumours (P = 0.01). CONCLUSIONS The imaging characteristics of cancers in patients under 40 years without proven gene mutations do not differ from their older counterparts, but appear correlated to phenotypic profiles, which have a different distribution in young women compared to the general population.

UI MeSH Term Description Entries
D007089 Image Enhancement Improvement of the quality of a picture by various techniques, including computer processing, digital filtering, echocardiographic techniques, light and ultrastructural MICROSCOPY, fluorescence spectrometry and microscopy, scintigraphy, and in vitro image processing at the molecular level. Image Quality Enhancement,Enhancement, Image,Enhancement, Image Quality,Enhancements, Image,Enhancements, Image Quality,Image Enhancements,Image Quality Enhancements,Quality Enhancement, Image,Quality Enhancements, Image
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008327 Mammography Radiographic examination of the breast. 3D-Mammography,Digital Breast Tomosynthesis,Digital Mammography,X-ray Breast Tomosynthesis,3D Mammography,3D-Mammographies,Breast Tomosyntheses, Digital,Breast Tomosyntheses, X-ray,Breast Tomosynthesis, Digital,Breast Tomosynthesis, X-ray,Digital Breast Tomosyntheses,Digital Mammographies,Mammographies,Mammographies, Digital,Mammography, Digital,X ray Breast Tomosynthesis,X-ray Breast Tomosyntheses
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002114 Calcinosis Pathologic deposition of calcium salts in tissues. Calcification, Pathologic,Calcinosis, Tumoral,Microcalcification,Microcalcinosis,Pathologic Calcification,Calcinoses,Calcinoses, Tumoral,Microcalcifications,Microcalcinoses,Tumoral Calcinoses,Tumoral Calcinosis
D002278 Carcinoma in Situ A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane. Carcinoma, Intraepithelial,Carcinoma, Preinvasive,Intraepithelial Neoplasms,Neoplasms, Intraepithelial,Intraepithelial Carcinoma,Intraepithelial Neoplasm,Neoplasm, Intraepithelial,Preinvasive Carcinoma
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Bénédicte Bullier, and Gaétan MacGrogan, and Hervé Bonnefoi, and Gabrielle Hurtevent-Labrot, and Edouard Lhomme, and Véronique Brouste, and Martine Boisserie-Lacroix
July 2019, European journal of breast health,
Bénédicte Bullier, and Gaétan MacGrogan, and Hervé Bonnefoi, and Gabrielle Hurtevent-Labrot, and Edouard Lhomme, and Véronique Brouste, and Martine Boisserie-Lacroix
November 2016, Revista da Associacao Medica Brasileira (1992),
Bénédicte Bullier, and Gaétan MacGrogan, and Hervé Bonnefoi, and Gabrielle Hurtevent-Labrot, and Edouard Lhomme, and Véronique Brouste, and Martine Boisserie-Lacroix
January 1985, Journal de gynecologie, obstetrique et biologie de la reproduction,
Bénédicte Bullier, and Gaétan MacGrogan, and Hervé Bonnefoi, and Gabrielle Hurtevent-Labrot, and Edouard Lhomme, and Véronique Brouste, and Martine Boisserie-Lacroix
January 2011, Journal of B.U.ON. : official journal of the Balkan Union of Oncology,
Bénédicte Bullier, and Gaétan MacGrogan, and Hervé Bonnefoi, and Gabrielle Hurtevent-Labrot, and Edouard Lhomme, and Véronique Brouste, and Martine Boisserie-Lacroix
March 2024, Journal of epidemiology and global health,
Bénédicte Bullier, and Gaétan MacGrogan, and Hervé Bonnefoi, and Gabrielle Hurtevent-Labrot, and Edouard Lhomme, and Véronique Brouste, and Martine Boisserie-Lacroix
September 1999, European journal of cancer (Oxford, England : 1990),
Bénédicte Bullier, and Gaétan MacGrogan, and Hervé Bonnefoi, and Gabrielle Hurtevent-Labrot, and Edouard Lhomme, and Véronique Brouste, and Martine Boisserie-Lacroix
May 2014, Breast cancer (Tokyo, Japan),
Bénédicte Bullier, and Gaétan MacGrogan, and Hervé Bonnefoi, and Gabrielle Hurtevent-Labrot, and Edouard Lhomme, and Véronique Brouste, and Martine Boisserie-Lacroix
May 2009, Oncology (Williston Park, N.Y.),
Bénédicte Bullier, and Gaétan MacGrogan, and Hervé Bonnefoi, and Gabrielle Hurtevent-Labrot, and Edouard Lhomme, and Véronique Brouste, and Martine Boisserie-Lacroix
July 2003, Annals of the Academy of Medicine, Singapore,
Bénédicte Bullier, and Gaétan MacGrogan, and Hervé Bonnefoi, and Gabrielle Hurtevent-Labrot, and Edouard Lhomme, and Véronique Brouste, and Martine Boisserie-Lacroix
April 2010, Breast (Edinburgh, Scotland),
Copied contents to your clipboard!